Diaceutics PLC (LON:DXRX - Get Free Report) insider Peter Keeling sold 750,000 shares of the company's stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of GBX 102 ($1.28), for a total value of £765,000 ($960,331.41).
Diaceutics Stock Performance
Shares of LON DXRX opened at GBX 104.50 ($1.31) on Wednesday. The company has a debt-to-equity ratio of 3.07, a quick ratio of 9.92 and a current ratio of 7.99. The stock has a 50 day moving average price of GBX 99.66 and a 200 day moving average price of GBX 94.53. The stock has a market capitalization of £88.49 million, a PE ratio of 10,500.00 and a beta of 0.42. Diaceutics PLC has a 52 week low of GBX 79 ($0.99) and a 52 week high of GBX 110 ($1.38).
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group reissued a "buy" rating and set a GBX 150 ($1.88) price target on shares of Diaceutics in a research report on Thursday, March 21st.
Get Our Latest Analysis on Diaceutics
Diaceutics Company Profile
(
Get Free Report)
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
